CSIMarket
 


Natera inc   (NTRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Natera Inc 's Leverage Ratio

NTRA's quarterly Leverage Ratio and Total Liabilities, Equity growth


Due to net new borrowings of 2%, Leverage Ratio fell to 0.86, below the Natera Inc 's average Leverage Ratio.

Within Medical Laboratories industry in the forth quarter 2023, 11 other companies have achieved lower Leverage Ratio than Natera Inc in the IV Quarter 2023. While Leverage Ratio total ranking has improved so far in the forth quarter 2023 to 870, from total ranking in the third quarter 2023 at 1556 .

Explain Leverage Ratio?
Who are NTRA Customers?
What are NTRA´s Total Liabilities?


NTRA Leverage Ratio (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Change 8.44 % 116.98 % 34.09 % 19.96 % 8.03 %
Y / Y Total Liabilities Change -2.68 % 1.14 % 4.9 % 10.76 % 17.75 %
Leverage Ratio MRQ 0.86 0.82 1.07 1 0.96
NTRA's Total Ranking # 870 # 1556 # 1961 # 1877 # 860
Seq. Equity Change -2.46 % 31.62 % -8.37 % -7.82 % 95.16 %
Seq. Total Liabilities Change 2 % 1.69 % -2.4 % -3.87 % 6 %



Leverage Ratio forth quarter 2023 Company Ranking
Within: No.
Medical Laboratories Industry # 12
Healthcare Sector # 213
Overall Market # 870


Leverage Ratio Statistics
High Average Low
50.45 3.17 0.15
(Mar 31 2019)   (Sep 30 2015)




Financial Statements
Natera Inc 's Equity $ 765 Millions Visit NTRA's Balance sheet
Natera Inc 's Total Liabilities $ 660 Millions Visit NTRA's Balance sheet
Source of NTRA's Sales Visit NTRA's Sales by Geography


Cumulative Natera Inc 's Leverage Ratio

NTRA's Leverage Ratio for the trailling 12 Months

NTRA Leverage Ratio

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity TTM Growth 8.44 % 116.98 % 34.09 % 19.96 % 8.03 %
Y / Y Total Liabilities TTM Growth -2.68 % 1.14 % 4.9 % 10.76 % 17.75 %
Leverage Ratio TTM 0.93 0.95 1.13 1.19 1.22
Total Ranking TTM # 48 # 9 # 1898 # 98 # 101
Seq. Equity TTM Growth -2.46 % 31.62 % -8.37 % -7.82 % 95.16 %
Seq. Total Liabilities TTM Growth 2 % 1.69 % -2.4 % -3.87 % 6 %


On the trailing twelve months basis Despite of the net new borrowings of 2% during the twelve months period ending in IV Quarter 2023 Natera Inc has managed to decrease Leverage Ratio in the IV Quarter 2023 to 0.93, below Natera Inc 's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Medical Laboratories industry NTRA recorded the lowest Leverage Ratio. While Leverage Ratio total ranking has deteriorated during the twelve months ending in the IV Quarter 2023, compared to the prior period, from 9 to 48.

Explain Leverage Ratio?
Who are NTRA Customers?
What are NTRA´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Medical Laboratories Industry # 0
Healthcare Sector # 14
Within the Market # 48


trailing twelve months Leverage Ratio Statistics
High Average Low
24.31 2.38 0.41
(Sep 30 2018)   (Mar 31 2017)




Companies with similar Leverage Ratio in the quarter ending Dec 31 2023, within Medical Laboratories Industry Leverage RatioDec 31 2023 MRQ Total LiabilitiesDec 31 2023 MRQ Equity
Inotiv Inc   2.10 $ 534.422  Millions$ 254.162  Millions
Exagen Inc   1.47 $ 33.274  Millions$ 22.694  Millions
National Research Corporation  1.42 $ 69.343  Millions$ 48.955  Millions
Fortrea Holdings Inc   1.23 $ 2,142.200  Millions$ 1,738.800  Millions
Charles River Laboratories International inc   1.21 $ 4,350.905  Millions$ 3,602.276  Millions
Laboratory Corporation Of America Holdings  1.12 $ 8,834.600  Millions$ 7,875.000  Millions
Exact Sciences Corporation  1.05 $ 3,296.650  Millions$ 3,145.305  Millions
Quest Diagnostics Inc  0.97 $ 6,148.000  Millions$ 6,342.000  Millions
Medpace Holdings Inc   0.96 $ 538.018  Millions$ 558.950  Millions
Natera inc   0.86 $ 659.760  Millions$ 765.327  Millions
Icon Plc  0.84 $ 7,749.120  Millions$ 9,240.743  Millions
Koninklijke Philips Nv  0.80 $ 10,756.480  Millions$ 13,508.320  Millions
Caredx Inc   0.79 $ 205.498  Millions$ 261.328  Millions
Hologic Inc  0.74 $ 3,432.700  Millions$ 4,653.800  Millions
Ispecimen inc   0.62 $ 6.078  Millions$ 9.741  Millions
Butterfly Network inc   0.38 $ 84.221  Millions$ 220.053  Millions
Sera Prognostics Inc   0.36 $ 25.283  Millions$ 70.158  Millions
Enzo Biochem Inc  0.35 $ 24.655  Millions$ 70.775  Millions
Incyte Corporation  0.31 $ 1,592.270  Millions$ 5,189.837  Millions

Date modified: 2024-02-29T16:18:19+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com